Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
orp-101 (1 trial)
Diarrhea (Phase 2)
Irritable Bowel Syndrome (Phase 2)
Syndrome (Phase 2)
Trials (1 total)
Trial APIs (1 total)